Velcade
Velcade is an originator product from Janssen-Cilag AG and is listed on the FOPH Specialities List. Swiss mandatory health insurance therefore reimburses it within the authorised indication. The public price ranges from CHF 176.30 to CHF 460.10 depending on the pack; the patient co-payment is 10 per cent plus the deductible.
Core data
- Authorisation holder
- Janssen-Cilag AG
- ATC code
- L01XG01
- IT group
- 07.16.10 Cytostatica
- Active substances
- Bortezomibum
- Preparation type
- Originator product
- On the SL since
- 01/06/2005
- Last price change
- 01/12/2024
- Co-payment
- 10%
Prices per pack
The ex-factory price is the authorisation holder's price; the public price adds the distribution share and VAT. Both are FOPH maximum prices: nothing above them may be charged.
| Dosage form | Pack size | Ex-factory price | Public price | Valid from | Cat. | GTIN |
|---|---|---|---|---|---|---|
| Trockensub 1 mg | Durchstf 1 Stk | CHF 148.27 | CHF 176.30 | 01/02/2010 | A | 7680569760022 |
| Trockensub 3.5 mg | Durchstf 1 Stk | CHF 410.05 | CHF 460.10 | 01/06/2005 | A | 7680569760015 |
Limitation
This preparation is reimbursed only under the conditions below. The text is the binding FOPH wording; outside those conditions basic insurance does not pay.
The FOPH publishes limitation texts in German, French and Italian only. The German wording is reproduced verbatim below.
In Kombination mit Melphalan und Prednison bei bisher unbehandelten Patienten mit multiplem Myelom.
Zur Behandlung von Patienten mit rezidivierendem/refraktärem multiplem Myelom, welche mindestens eine vorhergehende Therapie erhielten.
Die Therapien bedürfen der Kostengutsprache durch den Krankenversicherer nach vorgängiger Konsultation des Vertrauensarztes.
More preparations in this group
FAQ
Is Velcade covered by Swiss health insurance?
Yes, but only under conditions. Velcade is on the Specialities List with a limitation: basic insurance reimburses it only when the conditions in the limitation text are met, in some cases only after the insurer has granted cost approval.
What does Velcade cost in Switzerland?
The public price is the maximum price set by the FOPH and for Velcade ranges from CHF 176.30 to CHF 460.10 per pack. The ex-factory price ranges from CHF 148.27 to CHF 410.05. Pharmacies may not charge more, but may charge less.
Market access
Do you need your product on the Specialities List?
Questions about SL listing, prices or limitations? Contact Swiss Reimbursement.
- Independent directory
- Official FOPH data
- Website in eight languages